{
    "code": "52026831",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026831",
    "time": "2019-11-29 03:39:36",
    "許可證字號": "衛部藥輸字第026831號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/09\/06",
    "發證日期": "105\/09\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;艾威群&quot; 瑞吩坦尼凍晶乾燥注射劑2毫克",
    "英文品名": "Remifentanil ALVOGEN powder for concentrate for solution for injection or infusion 2mg",
    "適應症": "(1) 於成人全身麻醉之誘導時，作為止痛劑。\r\n(2) 於成人全身麻醉之維持時，作為止痛劑。",
    "劑型": "247凍晶乾粉注射劑",
    "包裝": "2毫克Type I玻璃小瓶裝 一百支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 32第二級管制藥品 5F免除銜接性試驗",
        "申請商名稱": "6201180767  衛生福利部食品藥物管理署管制藥品製藥工廠",
        "申請商地址": "台北市南港區忠孝東路六段467號地下一層",
        "主製造廠": ""
    },
    "CCC號列": "30049099520 醫藥製劑，含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808802200",
            "成分名稱": "Remifentanil",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PIL_ArtworkProof_CompID_12450_Round_14_revise-108-07-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026831&Seq=006&Type=9"
        },
        {
            "title": "Carton_ArtworkProof_CompID_12451_Round_3_revise-108-07-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026831&Seq=004&Type=8"
        },
        {
            "title": "Label-ArtworkProof_CompID_12449_Round_3-108-04-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026831&Seq=003&Type=8"
        }
    ]
}